Innogest to launch trio of €100m VC funds

Two of the vehicles will be healthcare-focused, with one directed at cardiovascular medicine and the other towards oncology. The third fund will be focused on digital technology.

Each fund will likely be in excess of €100m and will invest in 12-15 companies, with €10m tickets earmarked for each investment.

The firm's investment in Renovacor in August will form part of the new cardiovascular-focused fund. The $11m series-A for the cardiovascular gene therapy company also included Novartis Venture Fund, Broadview Ventures, BioAdvance and New Leaf Venture Partners.

Innogest most recent two funds were Innogest Capital, which closed on €53.8m in July 2007; and Innogest Capital II, which closed on €60m in July 2015. Most recently, it increased its investment in Supermercato24 as part of a €13m funding round led by Fondo Italiano d'Investimento. In June, it also led a €1.6m bridge round for food startup Soul-K.

Innogest acquires minority stakes in companies looking to raise at series-B stage, but they are also open to companies in series-A rounds.

Click here for a full data profile of Innogest Capital 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• Southern Europe
• healthcare
• Italy
• Venture
• Exclusive